Hypertonic/hyperoncotic solution in hypovolemic patients: experience in the emergency room.

Abstract

Hypertonic solutions have been studied extensively in the treatment of hypovolemic shock, both in experimental and clinical models. Safety, efficacy, and long-term effects on animals and patients have been evaluated. The present article reviews indications, safety, mortality rates, and outcome in patients with hemorrhagic hypovolemic shock who were treated after admission with a hypertonic/hyperoncotic solution under strict observation in the emergency room.

• Authors: Riad N Younes, Dario Birolini
• Journal: Revista do Hospital das Clinicas (Rev Hosp Clin Fac Med Sao Paulo) 2002 May-Jun Vol. 57 Issue 3 Pg. 124-8 ISSN: 0041-8781 [Print] Brazil
• PMID: 12118271 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Dextrans
• Plasma Substitutes
• Saline Solution, Hypertonic

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Dextrans (administration & dosage, therapeutic use)
• Double-Blind Method
• Emergencies
• Female
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Plasma Substitutes (therapeutic use)
• Prognosis
• Saline Solution, Hypertonic (administration & dosage, therapeutic use)
• Shock, Hemorrhagic (therapy)
• Treatment Outcome